Analyst Sees BioMarin Up Another 25%
BioMarin Pharmaceutical received a favorable analyst call from Merrill Lynch in Monday.
All Work
Chris Lange
Bullish Apple Analyst Gets Even More Bullish
Apple received a favorable analyst call from Canaccord Genuity that cited the growing iPhone user base, which should drive steady long-term sales and strong cash flows.
SteadyMed Files for IPO
Specialty pharmaceutical company SteadyMed has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering.
Why One Analyst Is Downgrading Exxon Mobil Now
Exxon Mobil received a downgrade Monday morning when Argus took a bearish look at the oil giant, based on expectations for much weaker realized liquids prices.
Micron Bull Makes the Case for a $50 Target
Micron Technology received a very bullish call from Credit Suisse on Monday, based on near-term tailwinds and the long-term growth outlook for memory.
Achillion Breaks Through Phase 2 HCV
Achillion Pharmaceuticals has announced updated interim results from an ongoing Phase 2 study and the stock saw a solid boost in Monday's trading.
Are State Tax Filings Safe Again as Intuit Resumes Filing?
Intuit announced that it has resumed e-filing of state income tax returns via TurboTax as of last Friday.
Top 10 Corporate Earnings for the Week Ahead
Corporate earnings season is just reaching its peak, and 24/7 Wall St. has put together a preview of some of the larger companies reporting in the coming week.
Credit Suisse Gives Up on Gilead, Sort Of
Credit Suisse downgraded Gilead Sciences to Neutral and lowered its price target, citing increased competition for hepatitis C drugs.
Is Exelis Getting Enough in the Buyout?
Exelis has announced that it entered into a definitive agreement to be acquired by Harris in a cash and stock deal that values Exelis at roughly $4.75 billion.
GoPro Finds Difficulty in Properly Communicating With Investors
GoPro is finding itself in the same position as many former hot IPOs have found themselves. They go from hot stocks to hot potatoes.
Huge Revisions Move Unemployment
The U.S. Department of Labor's latest Employment Situation report indicates that employers across the United States fell behind in hiring in January from December’s revised numbers.
Pandora Releases Sins of the Earnings World
Pandora Media reported disappointing fourth-quarter results on Thursday afternoon, and shares plunged in after-hours trading.
Activision Earnings and Buyback Dominated by Share Sale Filing and Guidance (Updated)
Activision Blizzard, one of the biggest and most well-known game producers in the world, reported its fourth-quarter results Thursday after the markets closed.
GoPro Earnings Reflect Stellar Holiday Sales [UPDATE]
GoPro S-1 FilingGoPro, Inc. (NASDAQ: GPRO) reported its fourth-quarter earnings Thursday after the markets closed. The extreme-action camera maker had $0.99 in earnings per share (EPS) and $633.9 in revenue against Thomson Reuters consensus…
More Proof of Accelerating Boston Scientific Turnaround
Boston Scientific is pushing forward in its long turnaround and is gathering more speed.
What to Expect From Pandora Earnings
Thursday after the markets close, Pandora Media is scheduled to report its fourth-quarter financial results.
What to Expect From GoPro Earnings
GoPro is scheduled to report its fourth-quarter earnings Thursday after the U.S. markets close.
Analyst Has 3 Levers for Much Higher Apple Price Target
Apple has received another favorable analyst call from Credit Suisse's Kulbinder Garcha in the wake of its most recent earnings report.
Are Teva’s Earnings Good Enough?
Prior to the markets opening Thursday, Teva Pharmaceutical reported its most recent financial results.